One of the lesser-known consequences of osteogenesis imperfecta – brittle bone disease – is an increased risk of eye diseases like glaucoma.

A popular type of data collection is helping Kellogg providers make visits more meaningful for patients and reduce wait times.

A newly approved stent designed to treat glaucoma is a new option for some patients at U-M’s Kellogg Eye Center, one of the first centers in the country to offer it.